Obstetric and Neonatal Outcomes in Pregnancies From a Dedicated Cystic Fibrosis‐Maternal Health Service: A Retrospective Study
BJOG: An International Journal of Obstetrics & Gynaecology · 2026
DOI: 10.1111/1471-0528.70075 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2026. Verfasst von Rebecca Scott und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department for Obstetric Medicine, Chelsea and Westminster Hospital, London, UK. Hauptthemen laut MEDLINE: Cystic Fibrosis, Pregnancy Outcome, Pregnancy Complications, Maternal Health Services. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health Research (NIHR) Imperial Biomedical Research Centre, King's Health Partners Clinical & Academic Innovation Fund, Royal Brompton and Harefield Hospital Charity.
Abstract (Originalsprache)
Objective
A comprehensive review of maternal, obstetric and neonatal outcomes in pregnancies in females with cystic fibrosis (fwCF) following the introduction of Elexacaftor/Tezacaftor/Ivacaftor (ETI) therapy in a novel, dedicated CF‐Maternal Health service.
Design
Retrospective data review from a CF‐Maternal Health service between September 2020 and February 2025.
Setting
A large adult‐CF service in London, UK. Population or Sample Pregnant fwCF attending the Royal Brompton Hospital CF Service.
Methods
Review of CF‐Maternal Health service data. Main Outcome Measures Maternal, obstetric and neonatal outcomes.
Results
Fifty‐three fwCF completed 67 pregnancies, with 69 infants born. There were no stillbirths, neonatal or maternal deaths. ETI‐therapy was reported in 81% of pregnancies. In fwCF without CF‐Diabetes, 57% developed gestational diabetes. Hospital admission to treat an infective pulmonary exacerbation was required in 31% of pregnancies. Forty‐five percent of pregnancies delivered vaginally; 78% of babies were born at term. A major congenital abnormality was diagnosed in 4% of infants. Baseline lung‐function correlated positively with birth‐weight and gestation at birth.
Conclusions
FwCF have improved maternal, obstetric and neonatal outcomes since the introduction of ETI‐therapy, within a dedicated CF‐Maternal Health service.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department for Obstetric Medicine, Chelsea and Westminster Hospital, London, UK.
- Department of Metabolism, Digestion and Reproduction, Imperial College, London, UK.
- Department of Adult Cystic Fibrosis, Royal Brompton Hospital, Part of Guys and St Thomas' NHS Foundation Trust, London, UK.
- National Heart and Lung Institute, Imperial College, London, UK.
ORCID-Profile: Rebecca Scott
Förderung
- National Institute for Health Research (NIHR) Imperial Biomedical Research Centre
- King's Health Partners Clinical & Academic Innovation Fund
- Royal Brompton and Harefield Hospital Charity
- National Institute for Health and Care Research
Zitieren
APA
Scott, R., Downes, A., Weitnauer, L., Dobra, R., Singh, N., Robinson, R., Diable, E., Collins, S., Bowman, E., Tobin, T., Jones, A., Simmonds, N., & Felton, I. (2026). Obstetric and Neonatal Outcomes in Pregnancies From a Dedicated Cystic Fibrosis‐Maternal Health Service: A Retrospective Study. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.70075
Vancouver
Scott R, Downes A, Weitnauer L, Dobra R, Singh N, Robinson R, et al. Obstetric and Neonatal Outcomes in Pregnancies From a Dedicated Cystic Fibrosis‐Maternal Health Service: A Retrospective Study. BJOG: An International Journal of Obstetrics & Gynaecology. 2026. doi:10.1111/1471-0528.70075
BibTeX
@article{Scott2026,
author = {Scott, Rebecca and Downes, Amy and Weitnauer, Ladina and Dobra, Rebecca and Singh, Natasha and Robinson, Rachel and Diable, Emily and Collins, Saraha and Bowman, Elaine and Tobin, Thomas and Jones, Andrew and Simmonds, Nicholas and Felton, Imogen},
title = {Obstetric and Neonatal Outcomes in Pregnancies From a Dedicated Cystic Fibrosis‐Maternal Health Service: A Retrospective Study},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2026},
doi = {10.1111/1471-0528.70075}
}
EUVIMED